Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density.
about
Red-clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial [ISRCTN42940165]Hereditary Breast-Ovarian Cancer Team of the University Medical Centre Groningen (UMCG) - a ReportExercise lowers estrogen and progesterone levels in premenopausal women at high risk of breast cancer.Updated clinical recommendations for the use of tibolone in Asian womenProgesterone--promoter or inhibitor of breast cancer.Hormone replacement therapy and false positive recall in the Million Women Study: patterns of use, hormonal constituents and consistency of effectTreatment of osteoporosis and reduction in risk of invasive breast cancer in postmenopausal women with raloxifene.Hormone replacement therapy in women with a history of breast cancer.Distribution of cyclooxygenases 1 and 2 in the uterus and breast of cynomolgus monkeys-effects of hormone treatment.Breast Tissue Composition and Immunophenotype and Its Relationship with Mammographic Density in Women at High Risk of Breast Cancer.Tibolone: a unique version of hormone replacement therapy.Pharmacokinetics of tibolone in early and late postmenopausal women.Where are we with postmenopausal hormone therapy in 2005?Breast cancer with different prognostic characteristics developing in Danish women using hormone replacement therapy.Adolescent intake of animal fat and red meat in relation to premenopausal mammographic density.Tibolone and breast cancer.Breast response to menopausal hormone therapy--aspects on proliferation, apoptosis and mammographic density.Comparing the effects of continuous hormone replacement therapy and tibolone on the genital tract of menopausal women; a randomized controlled trialAn Evidence-Based Systematic Review of Black cohosh (Cimicifuga racemosa, Actaea racemosa) by the Natural Standard Research Collaboration.Relationship Between Breast Density and Selective Estrogen-Receptor Modulators, Aromatase Inhibitors, Physical Activity, and Diet: A Systematic Review.Hormone replacement therapy dependent changes in breast cancer-related gene expression in breast tissue of healthy postmenopausal women.Differential impact of conventional and low-dose oral hormone therapy, tibolone and raloxifene on mammographic breast density, assessed by an automated quantitative method.Effects of tibolone on sulfatase pathway of estrogens metabolism and on growth of MCF-7 human breast tumors implanted in ovariectomized nude mice.Mechanisms for differential effects between natural progesterone and synthetic progestogens on normal breast tissue.Tibolone reduces osteoporotic fracture risk and breast cancer risk, but increases the risk of stroke.Ten years of treatment with tibolone 2.5 mg daily: effects on bone loss in postmenopausal women.Androgens and women at the menopause and beyond.Associations between serum testosterone levels, cell proliferation and progesterone receptor content in normal and malignant breast tissue in postmenopausal women.A comparative study of breast cell proliferation during hormone replacement therapy: effects of tibolon and continuous combined estrogen-progestogen treatment.The influence of 5-year therapy with tibolone on the lipid profile in postmenopausal women with mild hypercholesterolemia.Effect of hormone replacement therapy, tibolone and raloxifene on serum lipids, apolipoprotein A1, apolipoprotein B and lipoprotein(a) in Greek postmenopausal women.The effect of tibolone in postmenopausal women receiving tamoxifen after surgery for breast cancer: a randomised, double-blind, placebo-controlled trial.Postmenopausal hormone therapy with estradiol and norethisterone acetate and mammographic density: findings from a cross-sectional study among Norwegian women.Progestin may modify the effect of low-dose hormone therapy on mammographic breast density.Improved bleeding profile and tolerability of tibolone versus transdermal E2/NETA treatment in postmenopausal women with female sexual dysfunction.Stereoselectivity in metabolic 3-reduction of tibolone in healthy Chinese female volunteers.Clinical effects of tibolone in postmenopausal women after 5 years of tamoxifen therapy for breast cancer.Neutral effect of ultra-low-dose continuous combined estradiol and norethisterone acetate on mammographic breast density.Testosterone addition during menopausal hormone therapy: effects on mammographic breast density.Historical milestones in the development of tibolone (Livial®).
P2860
Q24794752-00A93CDE-3F90-4532-88ED-23629E4370DDQ33721575-E95DFD95-911B-40DB-B916-9B3D28987FB7Q33976413-11A7DB41-5786-4A6C-8038-082F5AFE4DB3Q34142418-57369832-1361-4D3E-A86C-D612DFFDA523Q34323606-3BBFFF11-FA6C-4C71-8B8F-9F7FBDA8BABDQ34480637-4269D67D-5998-4F7B-9AE3-F328CF8A3BAFQ34896573-3165A385-F8F9-40A9-8255-D5EB1C0B0918Q35081294-1D135B43-CF90-4B0E-B8F6-D4A224DFF157Q35227349-40F8223B-9111-4CD9-A655-585402106F67Q35674339-AFFEAF96-2AA9-4ADB-980A-FF55F97BA63EQ35693770-D747C6D7-64C5-4684-BD28-88ECAF40B32AQ35803972-A95CDA7C-CB2F-4908-8E02-649AC6DB064BQ36350786-BE5B8D13-B538-4FC8-BB6B-39046CC79C65Q36626131-40EA839B-1114-47AB-8890-316135A6BF62Q36633611-2D6C2C95-2558-49B4-A891-DB1D31B98338Q36636037-D0EE38E3-7E45-4FE3-9C6C-0A626EF610C5Q36761362-F0B4548B-B446-491D-9041-1A2FD6DEFE6CQ37035162-C11AF528-006F-44DF-B070-998ABA874DDBQ38242928-CC3E1B25-9450-4715-BACB-618AD2EF7DF2Q38821494-88873FD9-26BF-4347-BD6D-656091293449Q39702876-2B3371A3-52AA-4FE8-A374-1461AEC32BD6Q39839966-9C5A0E5C-14A6-4113-A3B1-B3110425309FQ40245148-5FA0BC15-10D5-4CCD-AACB-8A003B000784Q40953581-625CDF57-9781-439E-80AF-AF0386703B32Q43227535-9073C937-4D89-48D0-9CD0-2F4FCF032C38Q44355123-D655B901-28C9-4B92-94EB-4FC796E208C5Q44429302-D29F93C4-3564-4A86-AF65-8098AC9DF5D8Q44474112-8520C22B-E3C7-4B82-87DE-463739903D42Q44982963-9A40D29C-3A7F-4E6D-8CCB-D3F8F816149DQ45007010-77E7EE6F-97F3-4377-91B9-39CCF4BE61B7Q45043374-D111B3DA-EB63-4E2C-8145-EDDA83E725D8Q45233103-6F64C41B-2D20-44B6-B00C-CBE5F1F7ED91Q45786935-B54FF983-88AE-46ED-8B50-23815F8C6704Q46039879-FD666B97-4B33-4F04-95EB-20E90F3FCDE1Q46141973-B45F0C0F-1BE8-42AA-90BD-868DBC9339F2Q46811205-EF586631-520B-4063-B8C4-CAB47059CFE5Q46877675-7B835C50-3DBD-46B5-B6CA-852A5745895CQ48578668-98A55FBF-2CEF-42A7-96DF-C404341E4C88Q48580244-213D551C-08CB-41D3-B76F-793C8BBA5583Q48586031-60FBA3E5-21F4-45EA-8FA5-50801FB5DA2F
P2860
Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Effects of tibolone and contin ...... n mammographic breast density.
@en
Effects of tibolone and contin ...... n mammographic breast density.
@nl
type
label
Effects of tibolone and contin ...... n mammographic breast density.
@en
Effects of tibolone and contin ...... n mammographic breast density.
@nl
prefLabel
Effects of tibolone and contin ...... n mammographic breast density.
@en
Effects of tibolone and contin ...... n mammographic breast density.
@nl
P2093
P356
P1476
Effects of tibolone and contin ...... n mammographic breast density.
@en
P2093
Alexander Christow
Bo von Schoultz
Edward Azavedo
Eva Lundström
Gunilla Svane
Gunnar Söderqvist
Jan Barkfeldt
Mirjam Mol-Arts
Wendy Kersemaekers
P304
P356
10.1067/MOB.2002.121896
P407
P577
2002-04-01T00:00:00Z